A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)

Clinical trial NCT06144086 · COMPLETED

Trial details

NCT number: NCT06144086
Sponsor: Kiminori Kimura, MD
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Cirrhosis

Start date: 2024-05-08
Primary completion: 2025-03-27
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.